XML 120 R16.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Investments in associates
12 Months Ended
Dec. 31, 2023
Disclosure Of Investments In Associates [Abstract]  
Investments in associates [Text Block]

Note 11: Investments in associates

(a) Summarized financial information of the Company's investments in associates:

The carrying amounts of the Company's investments in associates as at December 31, 2023, were as follows:

    Dolly Varden     UMS     Total  
Carrying amount at December 31, 2021 $ -   $ -   $ -  
Acquisition of equity investment   60,439     151     60,590  
Disposal (note 1)   (12,280 )   -     (12,280 )
Company's share of net loss of associates   (5,856 )   (24 )   (5,880 )
Carrying amount at December 31, 2022 $ 42,303   $ 127   $ 42,430  
Company's share of net loss of associates   (6,177 )   (5 )   (6,182 )
Carrying amount at December 31, 2023 $ 36,126   $ 122   $ 36,248  

 

The quoted fair market value of the Company's interest in Dolly Varden at December 31, 2023 was $51,769 (December 31, 2022 - $53,554) based on the closing share price on that date.

On October 13, 2022, the Company completed the sale of 17,000,000 common shares of Dolly Varden, comprising 22.2% of the Company's equity interest in Dolly Varden acquired as part of the disposition of Homestake Resources (note 1), for total gross proceeds of $6,800. As at September 30, 2022, the sale was considered highly probable; therefore, the partial investment in associate represented by the 17,000,000 common shares was classified as an asset held for sale. The Company remeasured the carrying amount of the shares held for sale as the lower of cost and FVLCD and recognized an impairment expense of $5,506 in respect of the disposal. A reconciliation of the impairment expense is as follows:

Carrying amount, investment in Dolly Varden $ 55,265  
Equity interest transferred to held for sale   22.2%  
Carrying amount transferred to asset held for sale   12,280  
Less: FVLCD   (6,774 )
Impairment expense recognized $ 5,506  

For the year ended December 31, 2022, the Company's equity share of net loss of the Company's associates on a 100% basis were as follows:

Year ended December 31, 2022   Dolly Varden     UMS     Total  
Cost recoveries $ -   $ (4,412 ) $ (4,412 )
Exploration and evaluation   16,936     1,642     18,578  
Marketing   1,057     312     1,369  
Share-based compensation   1,786     2,433     4,219  
Administrative and other   (508 )   121     (387 )
Net loss of associate, 100%   19,271     96     19,367  
Average equity interest for the year   30.4%     25%        
Company's share of net loss of associates $ 5,856   $ 24   $ 5,880  

The net loss for the associates in 2022 includes the periods February 25, 2022 to December 31, 2022 for Dolly Varden and April 1, 2022 to December 31, 2022 for UMS as these are the periods they were considered to be equity investees.

For the year ended December 31, 2023, the Company's equity share of net loss of the Company's associates on a 100% basis were as follows:

Year ended December 31, 2023   Dolly Varden     UMS     Total  
Cost recoveries $ -   $ (5,517 ) $ (5,517 )
Exploration and evaluation   24,806     1,907     26,713  
Marketing   1,409     464     1,873  
Share-based compensation   1,971     -     1,971  
Administrative and other   (1,536 )   3,166     1,630  
Net loss of associate, 100%   26,650     20     26,670  
Average equity interest for the period   23.18%     25%        
Company's share of net loss of associates $ 6,177   $ 5   $ 6,182  
   

The Company's equity share of net assets of associates at December 31, 2022, is as follows:

    Dolly Varden     UMS  
Current assets $ 28,914   $ 879  
Non-current assets   155,198     2,750  
Current liabilities   (4,100 )   (1,654 )
Non-current liabilities   -     (1,467 )
Net assets, 100%   180,012     508  
Company's equity share of net assets of associate $ 42,303   $ 127  

The Company's equity share of net assets of associates at December 31, 2023, is as follows:

    Dolly Varden     UMS  
Current assets $ 11,468   $ 844  
Non-current assets   153,296     2,468  
Current liabilities   (804 )   (1,484 )
Non-current liabilities   -     (1,340 )
Net assets, 100%   163,960     488  
Company's equity share of net assets of associate $ 36,126   $ 122  

(b) Services rendered and balances with UMS

    Years ended December 31  
    2023     2022     2021  
Exploration and evaluation costs $ 872   $ 590   $ 215  
General and administration   714     841     384  
Total transactions for the year $ 1,586   $ 1,431   $ 599  

The outstanding balance owing at December 31, 2023 was $103 (December 31, 2022 - $240) which is included in accounts payable.

As part of the UMS arrangement, the Company is contractually obliged to pay certain rental expenses in respect of a ten-year office lease entered into by UMS on July 1, 2021. As at December 31, 2023, the Company expects to incur approximately $381 in respect of its share of future rental expense of UMS.

The Company issues share options to certain UMS employees, including key management personnel of the Company (note 16). The Company recognized a share-based compensation expense of $317 for the year ended December 31, 2023 in respect of share options issued to UMS employees (December 31, 2022 - $483, December 31, 2021 - $453) which is included within employee benefits and exploration and evaluation costs.